Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Aggen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Gene Therapy|July 15, 2011
Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chainsD H Aggen, A S Chervin, T M Schmitt, et al.
ESMO Open|June 6, 2025
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinomaM Sternschuss, N Toumbacaris, J P Das, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Gene Therapy|July 15, 2011
Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chainsD H Aggen, A S Chervin, T M Schmitt, et al.
ESMO Open|June 6, 2025
Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinomaM Sternschuss, N Toumbacaris, J P Das, et al.
Pageof 1